BrainStorm Cell Therapeutics , a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that the Company has received the third installment of the 2013 grant from Israel's Office of the Chief Scientist in the amount of approximately $335,000 .
http://www.biospace.com/news_story.aspx?StoryID=298979&full=1
http://www.biospace.com/news_story.aspx?StoryID=298979&full=1
No comments:
Post a Comment